Identical cohorts of patients are simulated by the model to compare costs and benefits for teriparatide treatment, bisphosphonate treatment, and no treatment. The simulated patients are defined by ...

HC Wainwright restated their buy rating on shares of Ligand Pharmaceuticals (NASDAQ:LGND – Free Report) in a report published ...

Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) have earned a consensus recommendation of “Buy” from the six brokerages that are covering the company, Marketbeat.com ...

Libra Therapeutics, Inc., ("Libra") a private biotech developing novel therapeutics to restore cellular balance and attenuate neurodegeneration, today announced the appointment of Shawn A. Scranton, ...

The first-line drugs for treatment of glucocorticoid-induced osteoporosis include bisphosphonates: alendronate and risedronate, while zoledronate or teriparatide should be considered as the second ...

Until now, the main options for women in this category have been UCB's Evenity (romosozumab) or Eli Lilly's Forsteo (teriparatide), with older generic bisphosphonates such as alendronic acid used ...

The new contract will establish new standards that may be used to enhance specificity and sensitivity across industry assay ...